News

Sanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus; DTaP-IPV) vaccine. The FDA granted approval for the vaccine for...

Agios Pharmaceuticals has received orphan drug designation from the US Food and Drug Administration (FDA) for its investigational medicine AG-348 to treat pyruvate kinase (PK) deficiency, a rare form of haemolytic anemia. PK deficiency is caused...

AstraZeneca has established a five-year research collaboration with Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells. AstraZeneca will use the technique in its screens of compound library...

The partnership will identify potent, selective and orally bioavailable small molecules that inhibit PTP1B activity in-vivo following stimulation by insulin and leptin to overcome resistance encountered in diabetes and obesity. Under the multi-year deal, CSHL and...

Japanese drug maker Takeda Pharmaceutical Company, through its wholly owned subsidiary Millennium Pharmaceuticals, has signed an agreement with US-based ImmunoGen to develop and commercialise anti-cancer therapeutics up to two undisclosed targets. As part of the deal,...

US-based Eli Lilly and Company has partnered with Chinese drug development firm Innovent Biologics to develop and commercialise three cancer treatments over the next decade. The deal will expand the presence of both firms in the...

Swedish firm Dilaforette has received orphan drug designation from the US Food and Drug Administration (FDA) for its sevuparin (DF02) to treat patients with sickle-cell disease (SCD). With an aim to start recruitment of patients during...